NEO1 and hepatocellular carcinoma: The marked increases of this cell surface fNeo1-TMD/ICD by γ-secretase inhibitors (Fig. S1) suggest that γ-secretase is the predominant protease to cleave Neo1 intracellular domain in hepatoma cells.